Learn More About What Metastatic Prostate Cancer Really Means

Metastatic prostate cancer means that prostate cancer has spread beyond the prostate to distant parts of the body. It is generally considered stage IV disease, but a metastatic diagnosis does not mean that treatment options are exhausted. Prostate cancer most commonly spreads to the bones, but it can also affect lymph nodes and organs such as the liver or lungs

Where Prostate Cancer Can Spread

Prostate cancer can spread to several locations outside the prostate.

Common sites include:

  • Bones.
  • Distant lymph nodes.
  • Liver.
  • Lungs.
  • Adrenal glands.

Bone is one of the most common sites of distant spread. Some people have no symptoms from metastases, while others may experience symptoms depending on where the cancer has spread.

What Symptoms Can Occur?

Metastatic prostate cancer does not always cause noticeable symptoms. When symptoms occur, they can vary significantly.

Possible symptoms include:

  • Persistent pain in the back, hips, or pelvis.
  • Bone pain.
  • Weakness or fatigue.
  • Urinary difficulties.
  • Shortness of breath if the lungs are affected.
  • Other symptoms related to the location of metastatic disease.

Some of these symptoms can also be caused by conditions unrelated to cancer, so medical evaluation is important.

Does Metastatic Mean There Is No Treatment?

No. Metastatic prostate cancer can often be treated, although treatment is usually focused on controlling the disease rather than eliminating it completely. Some people can live for years when metastatic cancer responds well to treatment.

Treatment choices depend on whether the cancer is still responding to hormone suppression, where it has spread, previous treatments, overall health, and other individual factors.

Hormone Therapy Is a Major Treatment

Prostate cancer often depends on male hormones called androgens to grow. Androgen deprivation therapy (ADT) lowers testosterone or prevents its effects on cancer cells and is a central treatment for metastatic prostate cancer.

Doctors may combine ADT with newer hormone medicines such as:

  • Abiraterone.
  • Enzalutamide.
  • Apalutamide.
  • Darolutamide.

For some patients with metastatic hormone-sensitive disease, combination treatment can provide better disease control than hormone suppression alone.

Other Treatment Options

Depending on the disease and previous treatment, doctors may also consider:

  • Chemotherapy, such as docetaxel.
  • Radiation therapy for selected tumors or painful bone metastases.
  • Radiopharmaceutical treatments for certain cancers that have spread to bone.
  • Targeted therapies, including PARP inhibitors for cancers with specific DNA-repair gene changes.
  • Immunotherapy for selected tumors with particular genetic characteristics.
  • Bone-strengthening treatments such as bisphosphonates or denosumab in appropriate circumstances.

Metastatic Prostate Cancer Can Change Over Time

Doctors may describe metastatic prostate cancer as castration-sensitive or castration-resistant.

Castration-sensitive disease continues to respond to testosterone suppression. Castration-resistant prostate cancer continues growing despite testosterone levels being reduced to very low levels. Additional treatments may still be available for castration-resistant disease.

This distinction is important because it can influence which treatments doctors consider next.

Managing Symptoms and Quality of Life

Cancer treatment isn't only about controlling tumor growth. Managing pain, urinary problems, fatigue, bone complications, and treatment side effects is also important.

Palliative care can be provided alongside cancer treatment to help manage symptoms and improve quality of life. It does not necessarily mean that cancer treatment has stopped.

Metastatic prostate cancer means that prostate cancer has spread to distant parts of the body, most commonly the bones. Although it is generally considered advanced or stage IV disease, metastatic does not mean untreatable. Hormone therapy, combination treatments, chemotherapy, radiation, targeted medicines, and other approaches can help control the disease and manage symptoms. The appropriate treatment depends on the individual's cancer characteristics, previous treatment, overall health, and response to therapy.